Volume 34, Issue 20, 21 May 2013

CardioPulse Articles

• Extract
• View article

When ‘digoxin use’ is not the same as ‘digoxin use’: lessons from the AFFIRM trial

• Extract
• View article

Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?

• Extract
• View article

Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society

• Extract
• View article
• Supplementary data

Biomarkers in atrial fibrillation: a clinical review

• Abstract
• View article

Increased mortality among patients taking digoxin—analysis from the AFFIRM study

• Abstract
• View article

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

• Abstract
• View article

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)

• Abstract
• View article

Isolated persistent left superior vena cava draining into the left atrium of an otherwise normal heart

• Extract
• View article
• Supplementary data

Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community

• Abstract
• View article
• Supplementary data

Double aortic arch

• Extract
• View article
• Supplementary data

Genetic variation in KCNA5: impact on the atrial-specific potassium current I_Kur in patients with lone atrial fibrillation

• Abstract
• View article
• Supplementary data